CoCo3 - Comprehensive Health Effects of Combined Contraceptives: a 12-month randomized, controlled, open-label trial of E4+DRSP, EE20μg+DRSP and DRSP-only
Фаза 4 – наблюдение след одобрението на пазара
Заболявания:
Contraception
Спонсор: Pohjois-Pohjanmaan hyvinvointialue, University Of Oulu
Налично на:
БГ
Обобщение
Trial status: Authorised
12-month use of study preparation, endpoint visit
Кой може да участва
Age group: 18-64 years
Gender: Female
Target enrollment: 156 participants
БГ
EN